Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

DOGE terminates billions in contracts, including $361K for ‘gender non-conforming, non-binary’ BIPOC farmers

by admin April 30, 2025
April 30, 2025
DOGE terminates billions in contracts, including $361K for ‘gender non-conforming, non-binary’ BIPOC farmers

The Department of Agriculture (USDA) terminad $2.5 billion in ‘wasteful’ grants that went toward gender-based causes, the Department of Government Efficiency (DOGE) said Tuesday. 

The USDA got rid of 420 grants for a savings of $2.3 billion, according to DOGE. 

Among the programs the money was used for, $361,000 went toward ‘gender non-conforming, non-binary, two-spirit’ BIPOC (Black, Indigenous, and people of color) farmers in New York.

Another $150,000 was used for ‘gender-lensed curricula designed to be transdisciplinary in the food, agriculture, natural resources and human sciences.’

Even Ghana benefited, with $100,000 earmarked for ‘climate resilience and sustainable agriculture’ in the African nation. 

In addition, federal agencies eliminated 179 contracts with a ceiling value of $1.87 billion and savings of $280 million. 

The federal government spent $207,000 on a U.S. Department of Health and Human Services consulting contract for a ‘grant writing workshop’ and an $89,000 Treasury Department contract for a ‘country program manager in Namibia.’

Another $1.8 million Trade & Development contract was spent on ‘energy and climate advisory services.’

This post appeared first on FOX NEWS

previous post
DOGE, Treasury discover $334M in improper payment requests due to foul codes
next post
Houston Rockets owner among trio of Trump ambassador nominees confirmed by Senate

Related Posts

Vance defends Gabbard as ‘critical part’ of Trump...

June 19, 2025

Democrat Congresswoman draws boos over ‘shameful’ sexism remark...

June 12, 2025

Trump says ‘I can’t believe I said that’...

February 28, 2025

Appeals court hears Medicaid fraud case that could...

September 27, 2025

When it comes to ID, it’s time to...

May 1, 2025

Republican doctors clash with RFK Jr over vaccines...

September 5, 2025

Israelis keep suitcases packed and ready as Trump...

February 21, 2026

Chaos in Syria sparks fears of ISIS prison...

January 24, 2026

Skies at stake: Inside the U.S.–China race for...

November 16, 2025

Ukrainian woman charged over Russian-backed cyberattacks; $10M reward...

December 11, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved